Prism gets go-ahead to build next-gen healthcare building
Construction is scheduled to begin in the first quarter of 2021 on a build-to-suit medical office building at Prism Capital Partners’ ON3 campus. The firm received final
Tag : biotech
Spear Street sells majority stake in PA science campus for $225M
New York-based Spear Street Capital has sold a majority share in a Philadelphia life science campus to a Saudia investor for $225 million. JLL Capital
Biotech firm signs lease at Winchester science campus.
WinchesterPartners, a joint venture of Twining Properties, L+M Development Partners and the Goldman Sachs Urban Investment Group, announced that Halda Therapeutics has signed a lease
Bio-tech company joins Industry City cohort
Industry City has announced today that Sight Diagnostics, a medical device company that provides accurate blood diagnostics from just two drops of blood in minutes, has joined the campus’ growing
Biotech leader to join Janus life science hub in Harlem
The Janus Property Company has signed a lease for lab space at The Mink Building with Volastra Therapeutics, a biotech company that works in the
Robert Martin Co. gets into life sciences
The Robert Martin Company is expanding into the life sciences/health tech industry. Laurence Gottlieb has been named Managing Director, Life Sciences and Health Technologies. Gottlieb
Research hub adds new biotech tenant
Taconic Investment Partners and Silverstein Properties, joint venture owners of The Hudson Research Center at 619 West 54th Street, have signed a lease with HiberCell,
Cushman & Wakefield brokers 45,000 s/f NJ pharma deal
Experic, LLC has leased 45,500 s/f at 2 Clarke Drive in Cranbury, a Class A research and office facility, announced Cushman & Wakefield. The location
Simone Development pushing for biotech boom in the Bronx
Simone Healthcare Development president Guy Leibler pitched the bio-tech business on the benefits of the Bronx. Speaking at the Bronx Tech Meetup held at the
Johnson & Johnson to open Soho lab
Pharmaceutical firm Johnson & Johnson is opening a 30,000 s/f life sciences facility at Edward J. Minskoff Equities’ 101 Avenue of the Americas. The incubator,